Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Sweden

 

Interview: Peter Graf, CEO, Tiohundra

Uniquely, we think in Europe, Tiohundra, an organisation serving a municipality of 62,000, has fully merged social care and health care delivery. Social care (elderly care, disabled care, homecare, psychiatry) and health care (hospitals and primary care) – have been melded in to a single organisation. So what are the learnings? And are we going […]

KRY’s Livi becomes biggest NHS supplier of telehealth

KRY's UK subsidiary Livi now has the biggest patient catchment by volume for telehealth consultations in the UK after signing three new deals with the NHS. HBI speaks to its UK country manager, Luke Buhl-Nielsen, about the expansion and its impact so far.

Bridgepoint “exploring” €2bn sale/IPO of Diaverum

As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.

Triton to buy Aleris for 18x EBITDA

Private equity group Triton is to acquire Aleris' healthcare services business, nine months after owner Investor AB sold off its social care segment. It values Aleris at 2.6-2.8bn SEK (€246-265m) or 17-18x 2018 EBITDA. 

Save millions, increase life expectancy, boost quality – what happens when you integrate care and healthcare

In almost all countries the provision of healthcare (hospitals, doctors) and social services (homecare, social workers, care homes) are siloed in many ways. Often the payors are different. Often, the two sides barely talk to each other. Often cultures are very different - healthcare can be very top down, for instance. But bringing ALL services together should create huge synergies, cost savings and a much stronger sense of community and empowerment.

Confirmed: Bergman buys Memira

As HBI exclusively predicted last week, Bergman Healthcare Clinics has announced it intends to acquire Swedish, Norwegian and Danish refractive eye care clinic chain Memira.

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 

Find Us